Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG -positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression

René Böttcher,David J. P. Henderson,Kalyan Dulla,D. van Strijp,L F Waanders,Gregor Tevz,Melanie L. Lehman,Dennis Merkle,G.J.L.H. Van Leenders,George S. Baillie,Guido Jenster,Miles D. Houslay,Ralf Hoffmann

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG -positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression

2015

René Böttcher
David J. P. Henderson
Kalyan Dulla
D. van Strijp
L F Waanders
Gregor Tevz
Melanie L. Lehman
Dennis Merkle
G.J.L.H. Van Leenders
George S. Baillie
Guido Jenster
Miles D. Houslay
Ralf Hoffmann

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG -positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression

Keywords:

Pathology
Androgen receptor
Medicine
Prostate cancer
Downregulation and upregulation
Endocrinology
Disease
Internal medicine
Phosphodiesterase
TMPRSS2
reduced risk
disease progression
Erg

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations